2006
DOI: 10.1111/j.1600-0501.2006.01303.x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical evaluation of demineralized bone allograft in a hyaluronic acid carrier for sinus lift augmentation in humans: a computed tomography and histomorphometric study

Abstract: This study confirmed the hypothesis that new bone formation is dependent on the DFDBA formulation used and demonstrated that DBX, alone or in combination with other materials, can be used successfully for sinus floor elevation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
98
0
7

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 95 publications
(110 citation statements)
references
References 11 publications
2
98
0
7
Order By: Relevance
“…4 Settable, weight-bearing bone grafts ideally exhibit both initial bone-like mechanical properties and also remodel with minimal resorption gaps such that the strength of the graft exceeds that of host bone during all stages of healing. Injectable bone void fillers (BVFs) include nonsetting allograft 5 and nonallogenic pastes, 6 which are typically delivered using viscous carriers (e.g., sodium hyaluronate, 7 glycerol, 8 or dextran 9 ) resulting in weak mechanical properties. Resorbable CPCs, [10][11][12][13] such as beta-tricalcium phosphate (b-TCP, slowly resorbed by osteoclasts) or calcium sulfate (CSH) and brushite (undergo dissolution), have also been used to enhance bone healing.…”
Section: Introductionmentioning
confidence: 99%
“…4 Settable, weight-bearing bone grafts ideally exhibit both initial bone-like mechanical properties and also remodel with minimal resorption gaps such that the strength of the graft exceeds that of host bone during all stages of healing. Injectable bone void fillers (BVFs) include nonsetting allograft 5 and nonallogenic pastes, 6 which are typically delivered using viscous carriers (e.g., sodium hyaluronate, 7 glycerol, 8 or dextran 9 ) resulting in weak mechanical properties. Resorbable CPCs, [10][11][12][13] such as beta-tricalcium phosphate (b-TCP, slowly resorbed by osteoclasts) or calcium sulfate (CSH) and brushite (undergo dissolution), have also been used to enhance bone healing.…”
Section: Introductionmentioning
confidence: 99%
“…To date, diverse approaches have been attempted to solve these problems caused by using xenogra particles. [7][8][9][10][11][12] One major approach is to employ a physical barrier using non-resorbable materials (e.g., titanium mesh and expanded polytetrauorethylene) or resorbable materials (e.g., collagen membrane, polylactic acid, polyglycolic acid, and polyurethane).…”
Section: Introductionmentioning
confidence: 99%
“…It presents osteoinductive and osteoconductive properties. These properties are known experimentally since the work of Urist in the 70s (16)(17)(18)(19). DBX consists in demineralised bone to which an organic carrier is added (sodium hyaluronate).…”
Section: Discussionmentioning
confidence: 99%
“…There is a lot of literature supporting its use as an accelerator of the bone healing. This biomaterial presents multiple applications in oral and craniomaxillofacial surgery (16)(17)(18)(19) . We have noticed that demineralised bone matrix accelerates significantly bone formation in the studied defect.…”
Section: Discussionmentioning
confidence: 99%